Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H14FN3O4 |
InChIKeyQZZJZXAWLQYJFK-HMQZJZAASA-N |
CAS Registry1134848-13-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | - | - | |
Neoplasms | Phase 1 | - | - | |
Neoplasms | Phase 1 | - | - |